Latest Euglenozoa Stories
The parasite Trypanosoma cruzi (or T cruzi), which causes Chagasâ€™ disease, will go to great lengths to evade death once it has infected human host cells, researchers have discovered.
Using an unconventional approach that they designed, University of Pittsburgh drug discoverers and their collaborators at Walter Reed Army Institute of Research have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world's most overlooked diseases.
Professor Albert Descoteaux's team at Centre INRS â€“ Institut Armand-Frappier has gained a better understanding of how the Leishmania donovani parasite manages to outsmart the human immune system and proliferate with impunity, causing visceral leishmaniasis, a chronic infection that is potentially fatal if left untreated.
Researchers at MUHC/McGill uncover key role played by a molecule in the process of infection used by the parasite that causes leishmania.
The parasites that cause leishmaniasis use a quirky trick to convince the immune system to effectively invite them into cells for dinner, according to a new study published today in PLoS Pathogens.
LEIDEN, The Netherlands, August 17 /PRNewswire/ -- A new consortium has been formed to boost drug development for the treatment of two deadly diseases, African sleeping sickness and Leishmaniasis, which affect millions of people worldwide.
The parasite Trypanosoma brucei, which causes African sleeping sickness, is like a thief donning a disguise. Every time the host's immune cells get close to destroying the parasite
For years, microbiologist Stephen Beverley, Ph.D., has tried to get the disease-causing parasite Leishmania in the mood for love.
SAN ANTONIO, March 5 /PRNewswire/ -- A plentiful, inexpensive, topical compound is as effective at treating the skin lesions of Middle Eastern and African leishmaniasis as is the standard therapy, a less-available, costlier compound injected into lesions.